Author

Ashish Prasad

Observed name: Dr. Ashish Prasad

Institution: USV (India)

Observed institution: USV (India)

ORCID: 0009-0009-5946-5412

Observed ORCID: 0009-0009-5946-5412

OpenAlex ID: A5031723792

Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus

2024 · Soumitra Ray, J Ezhilan, et al. · Journal of Diabetology · 8

The Use of Vildagliptin-Dapagliflozin Fixed Dose Combination in Different Patient Profiles in Indian Settings: An Opinion-Based Consensus

2023 · Dr. Umesh Kumar Garg, Dr. Ritesh Kumar Agrawala, et al. · International Journal of Current Science Research and Review · 7

Bioequivalence study of a fixed-dose combination of Dapagliflozin/ Vildagliptin Sustained Release tablets in healthy adult male subjects: A Randomized, Open-Label, Crossover Study

2022 · Ameya Joshi, Ashish Birla, et al. · Journal of Drug Delivery and Therapeutics · 5

Consensus to Reduce Withdrawal and Improve Adherence with SGLT2i: Consensus TWO SGLT2i Adherence Group

2025 · Nagendra K Singh, Akash Kumar Singh, et al. · Journal of the Association of Physicians of India · 3

FRI649 ADMIRE: Assessing Dapagliflozin And Metformin As An Initial Regimen In Diabetes Mellitus For Enhanced Glucose Control

2023 · Dr Uday Phadke, Dr Jayashree Gopal, et al. · Journal of the Endocrine Society · 3

Expert Consensus on Triple Combination of Glimepiride, Metformin, and Voglibose Usage in Patients with Type 2 Diabetes Mellitus in Indian Settings

2022 · Ashok K. Das, Subhash K. Wangnoo, et al. · Journal of Diabetology · 3

Expert Consensus Recommendations for Optimized Diabetes Care: Dapagliflozin and Sitagliptin Fixed-dose Combination in Indian Clinical Practice

2025 · Ambika G. Unnikrishnan, Ragini Bhake, et al. · Chronicle of Diabetes Research and Practice · 1

Synergizing sodium-dependent glucose transporter inhibitors with dipeptidyl-peptidase 4 inhibitor and metformin: a novel approach to diabetes management in Indi

2025 · Vageesh Ayyar, Tittu Ommen, et al. · International Journal of Basic & Clinical Pharmacology · 1

ADMIRE Study: Dapagliflozin and Metformin Fixed-dose Combination as Initial Choice of Therapy in Type 2 Diabetes Mellitus: A Real-world Study

2024 · Uday Phadke, Jayashree Gopal, et al. · Chronicle of Diabetes Research and Practice · 1

Pharmacokinetic and Pharmacodynamics Study of Multiple Oral Doses of Vildagliptin Sustained Release 100 Mg Tablets under the Fed State in Healthy Volunteers

2023 · Chetan Doshi, S B Sridhar, et al. · Journal of Drug Delivery and Therapeutics · 1

Glimepiride and Metformin Fixed-Dose Combination (FDC) along with Metformin + Dapagliflozin + Sitagliptin FDC in T2DM Patients with High Risk for Cardiovascular Disease: GRACE-CVD Study

2026 · L. S. Murthy, Anuj Jain, et al. · Journal of Diabetology

Triple Fixed-dose combination of Dapagliflozin, Sitagliptin, and Metformin for People with Type 2 Diabetes in Indian Settings

2024 · Rajashree Dhar, Ashish Prasad, et al. · Journal of Drug Delivery and Therapeutics

Works count: 12

Citation count: 33

H-index: 3

I10-index: